In addition, FGF2/FGFR1 signaling could regulate inflammation of hippocampus to exert a positive effect on some neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, and traumatic brain injury (Woodbury and Ikezu, 2014). Here, FGF2 is linked to multiple sclerosis.